Literature DB >> 29980278

Epithelial origin of eosinophilic esophagitis.

Mark Rochman1, Nurit P Azouz1, Marc E Rothenberg2.   

Abstract

Eosinophilic esophagitis (EoE) is a chronic, allergen-driven inflammatory disease of the esophagus characterized predominantly by eosinophilic inflammation, leading to esophageal dysfunction. Converging data have placed the esophageal epithelium at the center of disease pathogenesis. In particular, the main EoE disease susceptibility loci at 2p23 and 5p22 encode for gene products that are produced by the esophageal epithelium: the intracellular protease calpain 14 and thymic stromal lymphopoietin, respectively. Furthermore, genetic and functional data establish a primary role for impaired epithelial barrier function in disease susceptibility and pathoetiology. Additionally, the EoE transcriptome, a set of genes dysregulated in the esophagi of patients with EoE, is enriched in genes that encode for proteins involved in esophageal epithelial cell differentiation. This transcriptome has a high proportion of esophagus-specific epithelial genes that are notable for the unexpected enrichment in genes encoding for proteases and protease inhibitors, as well as in IL-1 family genes, demonstrating a previously unappreciated role for innate immunity responses in the esophagus under homeostatic conditions. Among these pathways, basal production of the serine protease inhibitor, Kazal-type 7 (SPINK7) has been demonstrated to be part of the normal differentiation program of esophageal epithelium. Profound lost expression of SPINK7 occurs in patients with EoE and is sufficient for unleashing increased proteolytic activity (including urokinase plasminogen activator), impaired barrier function, and production of large quantities of proinflammatory and proallergic cytokines, including thymic stromal lymphopoietin. Collectively, we put forth a model in which the esophagus is normally equipped as an anti-inflammatory sensing organ and that defects in this pathway, mediated by epithelial protease/protease inhibitor imbalances, unleash inflammatory responses resulting in disorders, such as EoE.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Eosinophilic esophagitis; Kazal type; eosinophilic oesophagitis; epithelial barrier; epithelial differentiation; esophageal epithelium; protease inhibitors; proteases; serine protease inhibitors

Mesh:

Substances:

Year:  2018        PMID: 29980278      PMCID: PMC8034427          DOI: 10.1016/j.jaci.2018.05.008

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  148 in total

1.  Evidence of an abnormal epithelial barrier in active, untreated and corticosteroid-treated eosinophilic esophagitis.

Authors:  D Simon; B Page; M Vogel; C Bussmann; C Blanchard; A Straumann; H-U Simon
Journal:  Allergy       Date:  2017-08-06       Impact factor: 13.146

2.  IgE allergen component-based profiling and atopic manifestations in patients with Netherton syndrome.

Authors:  Katariina Hannula-Jouppi; Satu-Leena Laasanen; Hannele Heikkilä; Mirja Tuomiranta; Marja-Leena Tuomi; Sirpa Hilvo; Nicolas Kluger; Sirpa Kivirikko; Alain Hovnanian; Soili Mäkinen-Kiljunen; Annamari Ranki
Journal:  J Allergy Clin Immunol       Date:  2014-08-23       Impact factor: 10.793

3.  Health-care utilization, costs, and the burden of disease related to eosinophilic esophagitis in the United States.

Authors:  Elizabeth T Jensen; Michael D Kappelman; Christopher F Martin; Evan S Dellon
Journal:  Am J Gastroenterol       Date:  2014-09-30       Impact factor: 10.864

4.  Eosinophilic esophagitis-linked calpain 14 is an IL-13-induced protease that mediates esophageal epithelial barrier impairment.

Authors:  Benjamin P Davis; Emily M Stucke; M Eyad Khorki; Vladislav A Litosh; Jeffrey K Rymer; Mark Rochman; Jared Travers; Leah C Kottyan; Marc E Rothenberg
Journal:  JCI Insight       Date:  2016-04

Review 5.  Interleukin-33 in health and disease.

Authors:  Foo Yew Liew; Jean-Philippe Girard; Heth Roderick Turnquist
Journal:  Nat Rev Immunol       Date:  2016-09-19       Impact factor: 53.106

6.  A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation.

Authors:  Carla A Borgoño; Iacovos P Michael; Nahoko Komatsu; Arumugam Jayakumar; Ravi Kapadia; Gary L Clayman; Georgia Sotiropoulou; Eleftherios P Diamandis
Journal:  J Biol Chem       Date:  2006-12-11       Impact factor: 5.157

7.  EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer.

Authors:  Luke Hughes-Davies; David Huntsman; Margarida Ruas; Francois Fuks; Jacqueline Bye; Suet-Feung Chin; Jonathon Milner; Lindsay A Brown; Forrest Hsu; Blake Gilks; Torsten Nielsen; Michael Schulzer; Stephen Chia; Joseph Ragaz; Anthony Cahn; Lori Linger; Hilal Ozdag; Elena Cattaneo; E S Jordanova; Edward Schuuring; David S Yu; Ashok Venkitaraman; Bruce Ponder; Aidan Doherty; Samuel Aparicio; David Bentley; Charles Theillet; Chris P Ponting; Carlos Caldas; Tony Kouzarides
Journal:  Cell       Date:  2003-11-26       Impact factor: 41.582

8.  Assessing Early Life Factors for Eosinophilic Esophagitis: Lessons From Other Allergic Diseases.

Authors:  Elizabeth T Jensen; Randi J Bertelsen
Journal:  Curr Treat Options Gastroenterol       Date:  2016-03

9.  A single progenitor population switches behavior to maintain and repair esophageal epithelium.

Authors:  David P Doupé; Maria P Alcolea; Amit Roshan; Gen Zhang; Allon M Klein; Benjamin D Simons; Philip H Jones
Journal:  Science       Date:  2012-07-19       Impact factor: 47.728

10.  A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis.

Authors:  Stephan Miehlke; Petr Hruz; Michael Vieth; Christian Bussmann; Ulrike von Arnim; Monther Bajbouj; Christoph Schlag; Ahmed Madisch; Christiane Fibbe; Henning Wittenburg; Hans Dieter Allescher; Max Reinshagen; Stefan Schubert; Jan Tack; Michaela Müller; Patrick Krummenerl; Joris Arts; Ralph Mueller; Karin Dilger; Roland Greinwald; Alex Straumann
Journal:  Gut       Date:  2015-03-19       Impact factor: 23.059

View more
  21 in total

Review 1.  The genetic etiology of eosinophilic esophagitis.

Authors:  Leah C Kottyan; Sreeja Parameswaran; Matthew T Weirauch; Marc E Rothenberg; Lisa J Martin
Journal:  J Allergy Clin Immunol       Date:  2020-01       Impact factor: 10.793

2.  Toll-like receptor 2 stimulation augments esophageal barrier integrity.

Authors:  Melanie A Ruffner; Li Song; Kelly Maurer; Lihua Shi; Margaret C Carroll; Joshua X Wang; Amanda B Muir; Jonathan M Spergel; Kathleen E Sullivan
Journal:  Allergy       Date:  2019-07-25       Impact factor: 13.146

3.  Epithelial HIF-1α/claudin-1 axis regulates barrier dysfunction in eosinophilic esophagitis.

Authors:  Joanne C Masterson; Kathryn A Biette; Juliet A Hammer; Nathalie Nguyen; Kelley E Capocelli; Bejan J Saeedi; Rachel F Harris; Shahan D Fernando; Lindsay B Hosford; Caleb J Kelly; Eric L Campbell; Stefan F Ehrentraut; Faria N Ahmed; Hiroshi Nakagawa; James J Lee; Eóin N McNamee; Louise E Glover; Sean P Colgan; Glenn T Furuta
Journal:  J Clin Invest       Date:  2019-07-02       Impact factor: 14.808

Review 4.  Eosinophilic esophagitis: Immune mechanisms and therapeutic targets.

Authors:  Dilawar Khokhar; Sahiti Marella; Gila Idelman; Joy W Chang; Mirna Chehade; Simon P Hogan
Journal:  Clin Exp Allergy       Date:  2022-07-19       Impact factor: 5.401

Review 5.  Eosinophilic esophagitis: imaging features with endoscopic and pathologic correlation.

Authors:  Patricia V Hernandez; Syed Amer; Dora M Lam-Himlin; David J DiSantis; Christine O Menias; Jennifer L Horsley-Silva
Journal:  Abdom Radiol (NY)       Date:  2020-03

Review 6.  How to approach adult patients with asymptomatic esophageal eosinophilia.

Authors:  Philipp Schreiner; Luc Biedermann; Thomas Greuter; Benjamin L Wright; Alex Straumann
Journal:  Dis Esophagus       Date:  2021-01-11       Impact factor: 3.429

Review 7.  Epithelial barrier repair and prevention of allergy.

Authors:  Elena Goleva; Evgeny Berdyshev; Donald Ym Leung
Journal:  J Clin Invest       Date:  2019-02-18       Impact factor: 14.808

8.  Clonally expanded, GPR15-expressing pathogenic effector TH2 cells are associated with eosinophilic esophagitis.

Authors:  Duncan M Morgan; Bert Ruiter; Neal P Smith; Ang A Tu; Brinda Monian; Brandon E Stone; Navneet Virk-Hundal; Qian Yuan; Wayne G Shreffler; J Christopher Love
Journal:  Sci Immunol       Date:  2021-08-13

9.  Functional role of kallikrein 5 and proteinase-activated receptor 2 in eosinophilic esophagitis.

Authors:  Nurit P Azouz; Andrea M Klingler; Purnima Pathre; John A Besse; Netali Ben Baruch-Morgenstern; Adina Y Ballaban; Garrett A Osswald; Michael Brusilovsky; Jeff E Habel; Julie M Caldwell; Mario A Ynga-Durand; Pablo J Abonia; Yueh-Chiang Hu; Ting Wen; Marc E Rothenberg
Journal:  Sci Transl Med       Date:  2020-05-27       Impact factor: 17.956

10.  Gastrointestinal Eosinophil Responses in a Longitudinal, Randomized Trial of Peanut Oral Immunotherapy.

Authors:  Benjamin L Wright; Nielsen Q Fernandez-Becker; Neeraja Kambham; Natasha Purington; Shu Cao; Dana Tupa; Wenming Zhang; Sayantani B Sindher; Matthew A Rank; Hirohito Kita; David A Katzka; Kelly P Shim; Bryan J Bunning; Alfred D Doyle; Elizabeth A Jacobsen; Mindy Tsai; Scott D Boyd; Monali Manohar; R Sharon Chinthrajah
Journal:  Clin Gastroenterol Hepatol       Date:  2020-05-17       Impact factor: 13.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.